Figure 4
Odds ratio for ocular adverse events in intravitreal faricimab and control groups. (A) Ocular adverse events. (B). Ocular serious adverse events.
Figure 4 | Scientific Reports
Odds ratio for ocular adverse events in intravitreal faricimab and control groups. (A) Ocular adverse events. (B). Ocular serious adverse events.
